First confirmed case of infant botulism in Africa, caused by a dual-toxin-producing Clostridium botulinum strain.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2021 Vol.103() p. 164-166

Vosloo MN, Opperman CJ, Geyer HDW, Setshedi GM, Allam M, Kwenda S, Ismail A, Khumalo ZTH, Brink AJ, Frean JA, Rossouw J

Abstract

Botulism, a rare life-threatening toxemia, is probably underdiagnosed in all of its forms in Africa. This study reports the first laboratory-supported case of infant botulism on the African continent. A 10-week-old, previously well infant presented with progressive global weakness, feeding difficulty, and aspiration pneumonia. During a lengthy hospitalization, a rare bivalent Clostridium botulinum strain, producing subtype B3 and F8 toxins and with a new multilocus sequence type, was isolated from stool. The infant was successfully treated with a heptavalent botulinum antitoxin infusion and pyridostigmine. Despite the relative rarity of infant botulism, this case illustrates the importance of maintaining a high level of clinical suspicion when assessing hypotonic infants. The value of modern diagnostic modalities in identifying and characterizing this under-recognized condition is also demonstrated.

MeSH Terms

Africa; Botulinum Toxins; Botulism; Clostridium botulinum; Hospitalization; Humans; Infant; Multilocus Sequence Typing